Print Page

Products found to contain undeclared medicines

The United States: Public Notification: Slimina contains hidden drug ingredient sibutramine
The US Food and Drug Administration (FDA) is advising consumers not to purchase or use Slimina, a product promoted and sold for weight loss on various websites, including, and possibly in some retail stores. FDA laboratory analysis confirmed that Slimina contains sibutramine. Sibutramine is a controlled substance that was removed from the market in Oct 2010 for safety reasons. This product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or heart rate in some people and may present a significant risk for people with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.

Please refer to the following website in FDA for details:

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/Friday, Jan 11, 2019
Issued at HKT 15:00
Related Information:
Canada: Undeclared drug ingredients may pose serious health risks Posted 2019-05-02
The United States: Nature’s Rx issues voluntary nationwide recall of Silver Bull... Posted 2019-01-31
Australia: Safety advisory: Germany Black Ant 2000mg tablets (Zhansheng Weige Ch... Posted 2019-01-15
The United States: Public Notification: The Silver Bullet contains hidden drug i... Posted 2019-01-11